The inclusion of STEMI Patient #204 (DBP 51 mmHg, Killip class I, GRACE Score 181, no hyperlipidaemia, CKMB 7.40 ng/mL, myoglobin 51.76 ng/mL, WBC 6.38 × 10^9/L, monocytes 0.40 × 10^9/L, TT 15.60 s, GLB 32.3 g/L, and CB 3.60 μmol/L) in the survival model enabled it to transition from predicting outcomes for the whole cohort to specific individuals. Here, MB is linked to hyperlipidemia.